logo

Mustang Bio Inc (MBIO)



Trade MBIO now with
  Date
  Headline
11/14/2017 8:36:21 AM Mustang Bio Q3 Net Loss Widens To $6.9 Mln Or $0.27/shr From $1.9 Mln Or $0.19/shr Last Year
11/14/2017 8:34:40 AM Mustang Bio Appoints Brian Achenbach As VP Of Finance And Corporate Controller
11/3/2017 5:34:15 AM ABUS Is Abuzz...
10/31/2017 7:41:16 AM Mustang Bio Reports Publication Of Preclinical Data For MB-103, Its Second-generation HER2 CAR T Cell Therapy